NASDAQ · Asset Management

ProFunds Biotechnology UltraSector Fund Service Class (BIPSX) Stock

$49.22 +0.59% NASDAQ: BIPSX Financial Services

This fund's investment strategy involves allocating capital to various financial instruments, carefully selected by its adviser, with the aim of achieving daily returns that align with its stated objectives. It seeks to track a specific index that measures the performance of select companies within the U.S.

Valuation

MetricValue
Price$49.22
Market Cap$191.77M
P/E Ratio1.93
P/B Ratio
P/S Ratio
EPS (TTM)$25.89
52-Week High$52.47
52-Week Low$20.79
Dividend Yield0.04%

Financials & Margins

MetricValue
ROE
ROA
ROCE
Gross Margin
Operating Margin
Net Margin
Debt/Equity
Current Ratio

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA
FCF Yield
Quick Ratio
Interest Coverage
Return 1Y136.84%
Return 3Y117.20%
Return 5Y68.71%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AADBXAmerican Beacon Balanced Fund R5 Class $15.56 +0.06% 62.24 $105.71M 1.86%
ALMRXAlger Mid Cap Growth Institutional I $30.92 -0.23% 43.62 $111.12M 17.55%
BCVBancroft Fund Ltd. $24.80 -0.04% 3.83 $144.40M 0.00%
CIGYXAB Cap Fund, Inc. - AB Concentrated International Growth Portfolio - ADV $11.69 -0.26% $108.97M 0.62%
CYPIXProFunds Consumer Services UltraSector Fund Investor Class $75.64 -0.22% 4.04 $80.51M 0.00%

About ProFunds Biotechnology UltraSector Fund Service Class

This fund's investment strategy involves allocating capital to various financial instruments, carefully selected by its adviser, with the aim of achieving daily returns that align with its stated objectives. It seeks to track a specific index that measures the performance of select companies within the U.S. biotechnology sector of the equity market. Notably, the fund employs a concentrated investment approach, meaning it is not diversified.

ProFunds Biotechnology UltraSector Fund Service Class is headquartered in US.

ProFunds Biotechnology UltraSector Fund Service Class (BIPSX) stock trades at $49.22 with a market capitalization of $191.77M. The stock is valued at a price-to-earnings (P/E) ratio of 1.93. Over the past 52 weeks the stock has ranged between $20.79 and $52.47, and currently trades 6.2% below its 52-week high. It pays a dividend yielding 0.04%.

Official website: www.profunds.com/mutual-funds/biotechnology

Related Financial Services Stocks

BRK.A Insurance - Diversified $733370.00 +0.00% BRK.B FIRE, MARINE & CASUALTY INSURANCE $482.70 +0.00% JPM Banks - Diversified $357.52 +0.34% V Financial - Credit Services $362.50 -2.15% MA Financial - Credit Services $562.95 -2.26% BAC Banks - Diversified $63.17 +0.27% HSBC Banks - Diversified $102.60 -1.06% MS Financial - Capital Markets $203.19 -3.97% GS Financial - Capital Markets $980.75 -5.09% RY Banks - Diversified $206.45 -2.79% WFC Banks - Diversified $83.87 -3.45% MUFG Banks - Diversified $21.94 -2.18%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)Exxon Mobil (XOM)

Screens featuring this stock

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides